Yin XY - Search Results

1

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ. Xu HX, et al. Among authors: yin xy. Clin Radiol. 2005 Sep;60(9):1018-25. doi: 10.1016/j.crad.2005.04.009. Clin Radiol. 2005. PMID: 16124984

2

Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.

Xu HX, Xie XY, Lu MD, Chen JW, Yin XY, Xu ZF, Liu GJ. Xu HX, et al. Among authors: yin xy. Clin Radiol. 2004 Jan;59(1):53-61. doi: 10.1016/j.crad.2003.09.006. Clin Radiol. 2004. PMID: 14697375

3

Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy.

Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Lu MD, et al. Among authors: yin xy. Br J Surg. 2005 Nov;92(11):1393-8. doi: 10.1002/bjs.5102. Br J Surg. 2005. PMID: 16044409

4

Color Doppler velocity profile assessment of portal hemodynamics in cirrhotic patients with portal hypertension: correlation with esophageal variceal bleeding.

Yin XY, Lu MD, Huang JF, Xie XY, Liang LJ. Yin XY, et al. J Clin Ultrasound. 2001 Jan;29(1):7-13. doi: 10.1002/1097-0096(200101)29:1<7::aid-jcu2>3.0.co;2-v. J Clin Ultrasound. 2001. PMID: 11180179

5

Significance of portal hemodynamic investigation in prediction of hepatic functional reserve in patients with hepatocellular carcinoma undergoing operative treatment.

Yin XY, Lu MD, Huang JF, Liang LJ. Yin XY, et al. Hepatogastroenterology. 2001 Nov-Dec;48(42):1701-4. Hepatogastroenterology. 2001. PMID: 11813604

6

Quantitative assessment of power Doppler mapping in the detection of renal allograft complications.

Lu MD, Yin XY, Wan GS, Xie XY. Lu MD, et al. Among authors: yin xy. J Clin Ultrasound. 1999 Jul-Aug;27(6):319-23. doi: 10.1002/(sici)1097-0096(199907/08)27:6<319::aid-jcu2>3.0.co;2-x. J Clin Ultrasound. 1999. PMID: 10395127 Clinical Trial.

7

Intraoperative liver ultrasound: the Chinese experience.

Lu MD, Yin XY, Huang JF. Lu MD, et al. Among authors: yin xy. Ultrasound Q. 2001 Mar;17(1):63-8. doi: 10.1097/00013644-200103000-00006. Ultrasound Q. 2001. PMID: 12973089

8

Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib.

Chen D, Zhao P, Li SQ, Xiao WK, Yin XY, Peng BG, Liang LJ. Chen D, et al. Among authors: yin xy. Eur J Surg Oncol. 2013 Sep;39(9):974-80. doi: 10.1016/j.ejso.2013.06.018. Epub 2013 Jul 8. Eur J Surg Oncol. 2013. PMID: 23845703

9

[Clinical study on treatment of middle-advanced stage liver cancer by combined treatment of hepatic artery chemoembolization with gan'ai no. I and no. II].

Shao ZX, Cheng ZG, Yin X. Shao ZX, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Mar;21(3):168-70. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001. PMID: 12577328 Clinical Trial. Chinese.

10

Novel variants of FSIP2 and SPEF2 cause varying degrees of spermatozoa damage in MMAF patients and favorable ART outcomes.

Dai CL, Yin XY, Peng ZY, Lin H, Zhang P, Liu G, Li WN. Dai CL, et al. Among authors: yin xy. J Assist Reprod Genet. 2025 Jan 3. doi: 10.1007/s10815-024-03378-1. Online ahead of print. J Assist Reprod Genet. 2025. PMID: 39753944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters